文献速递脑血管病

低频重复经颅磁刺激对大鼠缺血性卒中的神经保护作用

Neuroprotection of Low-Frequency Repetitive Transcranial Magnetic Stimulation after Ischemic Stroke in Rats.
PubMed 文献 · Ann Neurol · 2022-10-08

本研究在成年雄性大鼠局灶性脑缺血模型上,测试卒中后不同延迟(1.5、3、4、7小时)给予低频低强度重复经颅磁刺激(rTMS)的神经保护效果。结果显示1.5小时延迟rTMS使梗死体积减少35%,3或4小时延迟也可见保护作用;1.5或3小时延迟组在卒中后3至21天的感觉运动功能评估中表现显著优于卒中对照组。作者认为低频rTMS可能作为缺血性卒中后急性神经保护治疗是可行的。

要点

  • 大鼠卒中后1.5小时延迟rTMS使梗死体积较卒中对照组减少35%。
  • 3或4小时延迟rTMS也减少梗死体积和细胞死亡。
  • 1.5或3小时延迟rTMS组在卒中后3至21天感觉运动功能评估中显著优于卒中对照组。

核心结论

  • 作者认为,这些结果支持低频rTMS可能作为缺血性卒中后急性神经保护治疗是可行的。

研究设计与样本

  • 成年雄性大鼠接受右侧大脑中动脉闭塞60分钟的局灶性缺血手术。
  • 大鼠在卒中发作后1.5、3、4或7小时延迟接受rTMS或假治疗。
  • 低频低强度rTMS应用于大鼠脑,每次30分钟,共两次,中间间隔1小时。

主要发现

  • 卒中后3天,与卒中对照组相比,1.5小时延迟rTMS治疗的大鼠梗死体积减少35%。
  • 3或4小时延迟rTMS治疗也可见保护效应,表现为梗死体积和细胞死亡减少。
  • rTMS治疗上调抗凋亡因子Bcl-2,下调促凋亡因子caspase-3剪切、Bax和基质金属蛋白酶-9的表达。
  • 卒中后3至21天的感觉运动功能评估中,1.5或3小时延迟rTMS治疗的大鼠表现显著优于卒中对照组。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Stroke is a leading cause of human death and disability. Effective early treatments with reasonable therapeutic windows remain critically important to improve the outcomes of stroke. Transcranial magnetic stimulation (TMS) is an established noninvasive technique that has been applied clinically and in animal research for multiple brain disorders, but few studies have examined acute neuroprotection against ischemic stroke. The present investigation tested the novel approach of low-frequency repetitive TMS (rTMS) as an acute treatment after ischemic stroke. METHODS: Adult male rats received focal ischemic surgery through occlusion of the right middle cerebral artery for 60 minutes. The rats received either rTMS or sham treatment with 1.5-, 3-, 4-, or 7-hour delay after the onset of stroke. Low-frequency and low-intensity rTMS was applied to the rat brain for two 30-minute episodes separated by a 1-hour interval. RESULTS: Three days after stroke, compared to stroke controls, rats receiving rTMS treatment with a 1.5-hour delay showed a 35% reduction of infarct volume. Protective effects were also seen with 3- or 4-hour-delayed treatments by rTMS, shown as reduced infarct volume and cell death. rTMS treatment upregulated the antiapoptotic factor Bcl-2 and downregulated the proapoptotic caspase-3 cleavage, expressions of Bax and matrix metallopeptidase-9. In sensorimotor functional assessments 3 to 21 days after stroke, rats receiving rTMS treatment with a 1.5- or 3-hour delay showed significantly better performance compared to stroke controls. INTERPRETATION: These results support the inference that low-frequency rTMS may be feasible as a neuroprotective acute treatment after ischemic stroke. ANN NEUROL 2023;93:336-347.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Buetefisch CM, Wei L, Gu X, et al. Neuroprotection of Low-Frequency Repetitive Transcranial Magnetic Stimulation after Ischemic Stroke in Rats. Ann Neurol. 2022. PMID: 36097798. doi:10.1002/ana.26509

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。